Mesenchymal stem cells and the treatment of cardiac disease
JJ Minguell, A Erices - Experimental Biology and Medicine, 2006 - journals.sagepub.com
The ischemia-induced death of cardiomyocytes results in scar formation and reduced
contractility of the ventricle. Several preclinical and clinical studies have supported the …
contractility of the ventricle. Several preclinical and clinical studies have supported the …
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible
R Barzilay, E Melamed, D Offen - Stem cells, 2009 - academic.oup.com
Multipotent mesenchymal stem cells (MSCs) represent a promising autologous source for
regenerative medicine. Because MSCs can be isolated from adult tissues, they represent an …
regenerative medicine. Because MSCs can be isolated from adult tissues, they represent an …
Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis
RC Shroff, R McNair, N Figg, JN Skepper, L Schurgers… - Circulation, 2008 - Am Heart Assoc
Background—Vascular calcification is associated with increased morbidity and mortality in
stage V chronic kidney disease, yet its early pathogenesis and initiating mechanisms in vivo …
stage V chronic kidney disease, yet its early pathogenesis and initiating mechanisms in vivo …
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic …
A Vercelli, OM Mereuta, D Garbossa, G Muraca… - Neurobiology of …, 2008 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a lethal disease affecting motoneurons. In familial
ALS, patients bear mutations in the superoxide dismutase gene (SOD1). We transplanted …
ALS, patients bear mutations in the superoxide dismutase gene (SOD1). We transplanted …
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease
G Bouchez, L Sensebé, P Vourc'h, L Garreau… - Neurochemistry …, 2008 - Elsevier
Cellular therapy with adult stem cells appears as an opportunity for treatment of Parkinson's
disease. To validate this approach, we studied the effects of transplantation of rat adult bone …
disease. To validate this approach, we studied the effects of transplantation of rat adult bone …
Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity
Lineage-priming is a molecular model of stem cell (SC) differentiation in which proliferating
SCs express a subset of genes associated to the differentiation pathways to which they can …
SCs express a subset of genes associated to the differentiation pathways to which they can …
Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural …
JJ Montesinos, E Flores-Figueroa, S Castillo-Medina… - Cytotherapy, 2009 - Elsevier
Background Bone marrow (BM) has been recognized as the main source of mesenchymal
stromal cells (MSC); however, MSC have also been detected in umbilical cord blood (UCB) …
stromal cells (MSC); however, MSC have also been detected in umbilical cord blood (UCB) …
Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis
GP Lasala, JA Silva, PA Gardner, JJ Minguell - Angiology, 2010 - journals.sagepub.com
The infusion of a source of endothelial progenitors (EPCs) to limb ischemia (LB) patients has
been used to increase angiogenesis. Because the formation of new blood vessels involves …
been used to increase angiogenesis. Because the formation of new blood vessels involves …
[HTML][HTML] Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product
GP Lasala, JA Silva, JJ Minguell - The Journal of thoracic and …, 2012 - Elsevier
OBJECTIVE: Angiogenesis involves the interplay of endothelial progenitor cells, pericytes,
growth factors, and cellular matrix components. The use of mesenchymal stem cells, which …
growth factors, and cellular matrix components. The use of mesenchymal stem cells, which …
[HTML][HTML] Msx2 exerts bone anabolism via canonical Wnt signaling
SL Cheng, JS Shao, J Cai, OL Sierra… - Journal of Biological …, 2008 - ASBMB
Msx2 is a homeodomain transcription factor first identified in craniofacial bone and human
femoral osteoblasts. We hypothesized that Msx2 might activate skeletal Wnt signaling …
femoral osteoblasts. We hypothesized that Msx2 might activate skeletal Wnt signaling …